Repurposing two JAK inhibitors as a treatment for DMD
Duchenne UK
AGADA Biosciences
Test whether treatment with JAK inhibitors (Tofacitinib and Ruxolitinib) improves muscle function and histology in mdx mice.
5.1 Pharmaceuticals